Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3,182,163
-
Total 13F shares
-
38,993,325
-
Share change
-
-491,306
-
Total reported value
-
$516,277,406
-
Price per share
-
$13.24
-
Number of holders
-
98
-
Value change
-
-$7,521,445
-
Number of buys
-
61
-
Number of sells
-
24
Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q2 2021
As of 30 Jun 2021,
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,993,325 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, FRAZIER MANAGEMENT LLC, Versant Venture Management, LLC, BOXER CAPITAL, LLC, VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, HIGHLINE CAPITAL MANAGEMENT, L.P., and JPMORGAN CHASE & CO.
This page lists
98
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.